Literature DB >> 10597301

Overexpression of dominant negative PARP interferes with tumor formation of HeLa cells in nude mice: evidence for increased tumor cell apoptosis in vivo.

M A Hans1, M Müller, M Meyer-Ficca, A Bürkle, J H Küpper.   

Abstract

Poly(ADP-ribose) polymerase (PARP4) catalyzes the formation of ADP-ribose polymers covalently attached to proteins by using NAD+ as substrate. PARP is strongly activated by DNA single- or double-strand breaks and is thought to be involved in cellular responses to DNA damage. We characterized a dominant negative PARP mutant, i.e. the DNA-binding domain of this enzyme, whose overexpression in cells leads to increased genetic instability following DNA damage. In order to study whether PARP activity is also implicated in the process of tumorigenesis, we generated stably transfected HeLa cell clones with constitutive overexpression of dominant negative PARP and investigated tumor formation of these clones in nude mice. We found that inhibition of PARP activity dramatically reduces tumor forming ability of HeLa cells. Moreover, we provide strong evidence that the observed reduction in tumor forming ability is due to increased tumor cell apoptosis in vivo. Viewed together, our data and those from other groups show that inhibition of PARP enzyme activity interferes with DNA base excision repair and leads to increased genetic instability and recombination but, on the other hand, can sensitize cells to apoptotic stimuli and by this mechanism may prevent tumor formation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10597301     DOI: 10.1038/sj.onc.1203178

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

Review 1.  Manipulating the mammalian genome by homologous recombination.

Authors:  K M Vasquez; K Marburger; Z Intody; J H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

2.  Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice.

Authors:  C Conde; M Mark; F J Oliver; A Huber; G de Murcia; J Ménissier-de Murcia
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

3.  Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness.

Authors:  Pradip De; Yuling Sun; Jennifer H Carlson; Lori S Friedman; Brian R Leyland-Jones; Nandini Dey
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

4.  Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes.

Authors:  Anand G Patel; Karen S Flatten; Paula A Schneider; Nga T Dai; Jennifer S McDonald; Guy G Poirier; Scott H Kaufmann
Journal:  J Biol Chem       Date:  2011-12-12       Impact factor: 5.157

5.  PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males.

Authors:  Xue Mei Jin; Hee Nam Kim; Il-Kwon Lee; Kyeong-Soo Park; Hyeoung-Joon Kim; Jin-Su Choi; Sang Woo Juhng; Chan Choi
Journal:  BMC Med Genet       Date:  2010-03-03       Impact factor: 2.103

6.  PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition.

Authors:  Yasir H Ibrahim; Celina García-García; Violeta Serra; Lei He; Kristine Torres-Lockhart; Aleix Prat; Pilar Anton; Patricia Cozar; Marta Guzmán; Judit Grueso; Olga Rodríguez; Maria Teresa Calvo; Claudia Aura; Orland Díez; Isabel T Rubio; José Pérez; Jordi Rodón; Javier Cortés; Leif W Ellisen; Maurizio Scaltriti; José Baselga
Journal:  Cancer Discov       Date:  2012-08-22       Impact factor: 39.397

7.  Oral poly(ADP-ribose) polymerase-1 inhibitor BSI-401 has antitumor activity and synergizes with oxaliplatin against pancreatic cancer, preventing acute neurotoxicity.

Authors:  Davide Melisi; Valeria Ossovskaya; Cihui Zhu; Roberta Rosa; Jianhua Ling; Patrick M Dougherty; Barry M Sherman; James L Abbruzzese; Paul J Chiao
Journal:  Clin Cancer Res       Date:  2009-10-06       Impact factor: 12.531

8.  A comparative analysis of differentially expressed mRNAs, miRNAs and circRNAs provides insights into the key genes involved in the high-altitude adaptation of yaks.

Authors:  Qianyun Ge; Yongbo Guo; Wangshan Zheng; Yuan Cai; Xuebin Qi; Shengguo Zhao
Journal:  BMC Genomics       Date:  2021-10-15       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.